TME PHARMA N.V. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.249 EUR | +0.20% |
|
-0.99% | +8.26% |
Chart calendar TME Pharma N.V.
2ee1b3b6b94d2311ba1.8kmmw4KVWM1hLq2jpEfcOxirT5pf0cx8-Ua80rArgPY.tgD_u83la4U3YNzk8iWkcS7INe4ch75EyiqRlvVk1sOZD-uluvQ-qEx69A~4e6b2f18397959eab75a9600e2ac08ce
Upcoming events on TME Pharma N.V.
Past events on TME Pharma N.V.
| 25/04/2024 09:30 pm | Q4 2023 Earnings Release |
| 26/03/2024 | Glioblastoma Development Summit |
| 18/03/2024 | Bio Europe Spring Conference |
| 18/11/2023 09:00 am | Society for Neuro Oncology Meeting |
| 27/10/2023 09:30 pm | Q2 2023 Earnings Release |
| 21/10/2023 02:45 pm | European Society for Medical Oncology Congress |
| 29/06/2023 05:00 pm | Annual General Meeting |
| 03/06/2023 11:45 pm | American Society of Clinical Oncology Conference - abstract #2048 |
| 02/06/2023 | American Society of Clinical Oncology Conference |
| 24/04/2023 09:30 pm | Q4 2022 Earnings Release |
| 30/01/2023 06:00 pm | Extraordinary Shareholders Meeting |
| 22/11/2022 10:30 pm | Investor Meeting - Key Opinion Leader |
| 19/11/2022 06:00 am | Society for Neuro-Oncology Meeting - Abstract No: CTNI-67 |
| 26/10/2022 10:30 pm | Interim 2022 Earnings Release |
| 24/10/2022 | BIO Europe Conference |
| 21/09/2022 | Sachs Associates Biotech in Europe Forum |
| 09/09/2022 | ESMO Congress Conference |
| 29/06/2022 05:30 pm | Annual General Meeting |
| 10/06/2022 05:30 pm | Investor Meeting - Key Opinion Leader |
| 03/06/2022 | American Society of Clinical Oncology Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 6,60 - | 0,03 0,10 -66% |
|
EBITDA Million EUR | Released Forecast Spread | -3,90 -4,95 21.19% | 0,00 | -13,2 -5,20 -153.87% | -11,9 -16,3 26.77% |
|
EBIT Million EUR | Released Forecast Spread | -3,95 -5,05 21.82% | 0,00 | -13,3 -5,30 -150.32% | -12,0 -16,3 26.2% |
|
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
|
Net income Million EUR | Released Forecast Spread | -0,86 -5,50 84.35% | -10,4 | 0,00 0,00 - | 0,00 0,00 - |
|
EPS EUR | Released Forecast Spread | 0,00 0,00 - | -32,0 | 0,00 0,00 - | 0,00 0,00 - |
| Announcement Date | 22/04/20 | 28/04/21 | 22/04/22 | 24/04/23 |
More events
Past sector events for TME Pharma N.V.
| Today | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| Today | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 10:30 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 26/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 26/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 04:30 pm | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 11:30 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Annual - Rate of surprise
- Stock Market
- Equities
- ALTME Stock
- Calendar TME Pharma N.V.
